Cita APA

Sancho, J. M., Salar, A., & Rubio-Azpeitia, E. (2022). IBRORS-MCL study: A Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice.

Citación estilo Chicago

Sancho, Juan Manuel, Antonio Salar, y Eva Rubio-Azpeitia. IBRORS-MCL Study: A Spanish Retrospective and Observational Study of Relapsed/refractory Mantle-cell Lymphoma Treated With Ibrutinib in Routine Clinical Practice. 2022.

Cita MLA

Sancho, Juan Manuel, Antonio Salar, y Eva Rubio-Azpeitia. IBRORS-MCL Study: A Spanish Retrospective and Observational Study of Relapsed/refractory Mantle-cell Lymphoma Treated With Ibrutinib in Routine Clinical Practice. 2022.